Warfarin in the prevention of stroke associated with nonrheumatic atrial fibrillation. Veterans Affairs Stroke Prevention in Nonrheumatic Atrial Fibrillation Investigators

A correction has been published: N Engl J Med 1993;328(2):148.

Volume 327:1406-1412		November 12, 1992		Number 20

Warfarin in the prevention of stroke associated with nonrheumatic atrial fibrillation. Veterans Affairs Stroke Prevention in Nonrheumatic Atrial Fibrillation Investigators

MD Ezekowitz, SL Bridgers, KE James, NH Carliner, CL Colling, CC Gornick, H Krause-Steinrauf, JF Kurtzke, SM Nazarian, MJ Radford, and et al.

Abstract

Add to Personal Archive

Add to Citation Manager

E-mail When Cited

Related Article

PubMed Citation

Cardiovascular Section, Department of Veterans Affairs Medical Center, West Haven, CT.

This article has been cited by other articles:

Holmes, D. R. Jr, Schwartz, R. S. (2009). Left Atrial Appendage Occlusion Eliminates the Need for Warfarin. Circulation 120: 1919-1926 [Full Text]
Whitlock, R. P., Healey, J. S., Connolly, S. J. (2009). Left Atrial Appendage Occlusion Does Not Eliminate the Need for Warfarin. Circulation 120: 1927-1932 [Full Text]
Chan, K. E., Lazarus, J. M., Thadhani, R., Hakim, R. M. (2009). Warfarin Use Associates with Increased Risk for Stroke in Hemodialysis Patients with Atrial Fibrillation. J. Am. Soc. Nephrol. 20: 2223-2233 [Abstract] [Full Text]
Ellis, D. J., Usman, M. H., Milner, P. G., Canafax, D. M., Ezekowitz, M. D. (2009). The First Evaluation of a Novel Vitamin K Antagonist, Tecarfarin (ATI-5923), in Patients With Atrial Fibrillation. Circulation 120: 1029-1035 [Abstract] [Full Text]
Edwin, F., Tettey, M. M., Aniteye, E., Sereboe, L., Tamatey, M., Entsua-Mensah, K., Kotei, D., Frimpong-Boateng, K. (2009). Freedom from thromboembolism despite prolonged inadequate anticoagulation. BMJ Case Reports 2009: bcr0720092066-bcr0720092066 [Abstract] [Full Text]
Crandall, M. A., Bradley, D. J., Packer, D. L., Asirvatham, S. J. (2009). Contemporary Management of Atrial Fibrillation: Update on Anticoagulation and Invasive Management Strategies. Mayo Clin Proc. 84: 643-662 [Abstract] [Full Text]
van Walraven, C., Hart, R. G., Connolly, S., Austin, P. C., Mant, J., Hobbs, F.D. R., Koudstaal, P. J., Petersen, P., Perez-Gomez, F., Knottnerus, J. A., Boode, B., Ezekowitz, M. D., Singer, D. E. (2009). Effect of Age on Stroke Prevention Therapy in Patients With Atrial Fibrillation: The Atrial Fibrillation Investigators. Stroke 40: 1410-1416 [Abstract] [Full Text]
Friberg, L., Hammar, N., Rosenqvist, M. (2009). Stroke in paroxysmal atrial fibrillation: report from the Stockholm Cohort of Atrial Fibrillation. Eur Heart J 0: ehn599v1-9 [Abstract] [Full Text]
Andersen, L V, Vestergaard, P, Deichgraeber, P, Lindholt, J S, Mortensen, L S, Frost, L (2008). Warfarin for the prevention of systemic embolism in patients with non-valvular atrial fibrillation: a meta-analysis. Heart 94: 1607-1613 [Abstract] [Full Text]
2006 WRITING COMMITTEE MEMBERS, , Bonow, R. O., Carabello, B. A., Chatterjee, K., de Leon, A. C. Jr, Faxon, D. P., Freed, M. D., Gaasch, W. H., Lytle, B. W., Nishimura, R. A., O'Gara, P. T., O'Rourke, R. A., Otto, C. M., Shah, P. M., Shanewise, J. S. (2008). 2008 Focused Update Incorporated Into the ACC/AHA 2006 Guidelines for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 1998 Guidelines for the Management of Patients With Valvular Heart Disease): Endorsed by the Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons. Circulation 118: e523-e661 [Full Text]
Bonow, R. O., Carabello, B. A., Chatterjee, K., de Leon, A. C. Jr, Faxon, D. P., Freed, M. D., Gaasch, W. H., Lytle, B. W., Nishimura, R. A., O'Gara, P. T., O'Rourke, R. A., Otto, C. M., Shah, P. M., Shanewise, J. S., Nishimura, R. A., Carabello, B. A., Faxon, D. P., Freed, M. D., Lytle, B. W., O'Gara, P. T., O'Rourke, R. A., Shah, P. M. (2008). 2008 Focused Update Incorporated Into the ACC/AHA 2006 Guidelines for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 1998 Guidelines for the Management of Patients With Valvular Heart Disease) Endorsed by the Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons. J Am Coll Cardiol 52: e1-e142 [Full Text]
Knecht, S., Oelschlager, C., Duning, T., Lohmann, H., Albers, J., Stehling, C., Heindel, W., Breithardt, G., Berger, K., Ringelstein, E. B., Kirchhof, P., Wersching, H. (2008). Atrial fibrillation in stroke-free patients is associated with memory impairment and hippocampal atrophy. Eur Heart J 29: 2125-2132 [Abstract] [Full Text]
Ansell, J., Hirsh, J., Hylek, E., Jacobson, A., Crowther, M., Palareti, G. (2008). Pharmacology and Management of the Vitamin K Antagonists: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest 133: 160S-198S [Abstract] [Full Text]
Schulman, S., Beyth, R. J., Kearon, C., Levine, M. N. (2008). Hemorrhagic Complications of Anticoagulant and Thrombolytic Treatment: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest 133: 257S-298S [Abstract] [Full Text]
Singer, D. E., Albers, G. W., Dalen, J. E., Fang, M. C., Go, A. S., Halperin, J. L., Lip, G. Y. H., Manning, W. J. (2008). Antithrombotic Therapy in Atrial Fibrillation: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest 133: 546S-592S [Abstract] [Full Text]
Salem, D. N., O'Gara, P. T., Madias, C., Pauker, S. G. (2008). Valvular and Structural Heart Disease: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest 133: 593S-629S [Abstract] [Full Text]
Levi, M., Hovingh, G. K., Cannegieter, S. C., Vermeulen, M., Buller, H. R., Rosendaal, F. R. (2008). Bleeding in patients receiving vitamin K antagonists who would have been excluded from trials on which the indication for anticoagulation was based. Blood 111: 4471-4476 [Abstract] [Full Text]
Hansen, M. L., Gadsboll, N., Gislason, G. H., Abildstrom, S. Z., Schramm, T. K., Folke, F., Friberg, J., Sorensen, R., Rasmussen, S., Poulsen, H. E., Kober, L., Madsen, M., Torp-Pedersen, C. (2008). Atrial fibrillation pharmacotherapy after hospital discharge between 1995 and 2004: a shift towards beta-blockers. Europace 10: 395-402 [Abstract] [Full Text]
Garwood, C. L, Corbett, T. L (2008). Use of Anticoagulation in Elderly Patients with Atrial Fibrillation Who Are at Risk for Falls. The Annals of Pharmacotherapy 42: 523-532 [Abstract] [Full Text]
Hertzberg, V., Chimowitz, M., Lynn, M., Chester, C., Asbury, W., Cotsonis, G. (2008). Use of dose modification schedules is effective for blinding trials of warfarin: evidence from the WASID study. Clin Trials 5: 23-30 [Abstract]
Hohnloser, S. H., Pajitnev, D., Pogue, J., Healey, J. S., Pfeffer, M. A., Yusuf, S., Connolly, S. J., for the ACTIVE W Investigators, (2007). Incidence of Stroke in Paroxysmal Versus Sustained Atrial Fibrillation in Patients Taking Oral Anticoagulation or Combined Antiplatelet Therapy: An ACTIVE W Substudy. J Am Coll Cardiol 50: 2156-2161 [Abstract] [Full Text]
Kirchhof, P., Auricchio, A., Bax, J., Crijns, H., Camm, J., Diener, H.-C., Goette, A., Hindricks, G., Hohnloser, S., Kappenberger, L., Kuck, K.-H., Lip, G. Y.H., Olsson, B., Meinertz, T., Priori, S., Ravens, U., Steinbeck, G., Svernhage, E., Tijssen, J., Vincent, A., Breithardt, G. (2007). Outcome parameters for trials in atrial fibrillation: executive summary: Recommendations from a consensus conference organized by the German Atrial Fibrillation Competence NETwork (AFNET) and the European Heart Rhythm Association (EHRA). Eur Heart J 28: 2803-2817 [Abstract] [Full Text]
Nutescu, E. A. (2007). ASHP Therapeutic Position Statement on Antithrombotic Therapy in Chronic Atrial Fibrillation. Am J Health Syst Pharm 64: 2281-2291 [Full Text]
Kirchhof, P., Auricchio, A., Bax, J., Crijns, H., Camm, J., Diener, H.-C., Goette, A., Hindricks, G., Hohnloser, S., Kappenberger, L., Kuck, K.-H., Lip, G. Y.H., Olsson, B., Meinertz, T., Priori, S., Ravens, U., Steinbeck, G., Svernhage, E., Tijssen, J., Vincent, A., Breithardt, G. (2007). Outcome parameters for trials in atrial fibrillation: Recommendations from a consensus conference organized by the German Atrial Fibrillation Competence NETwork and the European Heart Rhythm Association. Europace 9: 1006-1023 [Abstract] [Full Text]
Habara, S., Dote, K., Kato, M., Sasaki, S., Goto, K., Takemoto, H., Hasegawa, D., Matsuda, O. (2007). Prediction of left atrial appendage thrombi in non-valvular atrial fibrillation. Eur Heart J 28: 2217-2222 [Abstract] [Full Text]
Connolly, S. J., Eikelboom, J., O'Donnell, M., Pogue, J., Yusuf, S. (2007). Challenges of Establishing New Antithrombotic Therapies in Atrial Fibrillation. Circulation 116: 449-455 [Full Text]
Hart, R. G., Pearce, L. A., Aguilar, M. I. (2007). Meta-analysis: Antithrombotic Therapy to Prevent Stroke in Patients Who Have Nonvalvular Atrial Fibrillation. ANN INTERN MED 146: 857-867 [Abstract] [Full Text]
Authors/Task Force Members, , Ryden, L., Standl, E., Bartnik, M., Berghe, G. V. d., Betteridge, J., de Boer, M.-J., Cosentino, F., Jonsson, B., Laakso, M., Malmberg, K., Priori, S., Ostergren, J., Tuomilehto, J., Thrainsdottir, I., Other Contributors, , Vanhorebeek, I., Stramba-Badiale, M., Lindgren, P., Qiao, Q., ESC Committee for Practice Guidelines (CPG), , Priori, S. G., Blanc, J.-J., Budaj, A., Camm, J., Dean, V., Deckers, J., Dickstein, K., Lekakis, J., McGregor, K., Metra, M., Morais, J., Osterspey, A., Tamargo, J., Zamorano, J. L., Document Reviewers, , Deckers, J. W., Bertrand, M., Charbonnel, B., Erdmann, E., Ferrannini, E., Flyvbjerg, A., Gohlke, H., Juanatey, J. R. G., Graham, I., Monteiro, P. F., Parhofer, K., Pyorala, K., Raz, I., Schernthaner, G., Volpe, M., Wood, D. (2007). Guidelines on diabetes, pre-diabetes, and cardiovascular diseases: full text: The Task Force on Diabetes and Cardiovascular Diseases of the European Society of Cardiology (ESC) and of the European Association for the Study of Diabetes (EASD). Eur Heart J Suppl 9: C3-C74 [Full Text]
Holbrook, A., Labiris, R., Goldsmith, C. H., Ota, K., Harb, S., Sebaldt, R. J. (2007). Influence of decision aids on patient preferences for anticoagulant therapy: a randomized trial. CMAJ 176: 1583-1587 [Abstract] [Full Text]
Chan, P. S., Nallamothu, B. K., Gurm, H. S., Hayward, R. A., Vijan, S. (2007). Incremental Benefit and Cost-Effectiveness of High-Dose Statin Therapy in High-Risk Patients With Coronary Artery Disease. Circulation 115: 2398-2409 [Abstract] [Full Text]
Perez-Gomez, F., Iriarte, J. A., Zumalde, J., Berjon, J., Salvador, A., Alegria, E., Maluenda, M. P., Asenjo, S., Perez-Saldana, R., de la Torre, R. G., Bover, R., Fernandez, C. (2007). Antithrombotic therapy in elderly patients with atrial fibrillation: effects and bleeding complications: a stratified analysis of the NASPEAF randomized trial. Eur Heart J 28: 996-1003 [Abstract] [Full Text]
Rash, A., Downes, T., Portner, R., Yeo, W. W., Morgan, N., Channer, K. S. (2007). A randomised controlled trial of warfarin versus aspirin for stroke prevention in octogenarians with atrial fibrillation (WASPO). Age Ageing 36: 151-156 [Abstract] [Full Text]
Glazer, N. L., Dublin, S., Smith, N. L., French, B., Jackson, L. A., Hrachovec, J. B., Siscovick, D. S., Psaty, B. M., Heckbert, S. R. (2007). Newly Detected Atrial Fibrillation and Compliance With Antithrombotic Guidelines. Arch Intern Med 167: 246-252 [Abstract] [Full Text]
Authors/Task Force Members, , Ryden, L., Standl, E., Bartnik, M., Van den Berghe, G., Betteridge, J., de Boer, M.-J., Cosentino, F., Jonsson, B., Laakso, M., Malmberg, K., Priori, S., Ostergren, J., Tuomilehto, J., Thrainsdottir, I., Other Contributors, , Vanhorebeek, I., Stramba-Badiale, M., Lindgren, P., Qiao, Q., ESC Committee for Practice Guidelines (CPG), , Priori, S. G., Blanc, J.-J., Budaj, A., Camm, J., Dean, V., Deckers, J., Dickstein, K., Lekakis, J., McGregor, K., Metra, M., Morais, J., Osterspey, A., Tamargo, J., Zamorano, J. L., Document Reviewers, , Deckers, J. W., Bertrand, M., Charbonnel, B., Erdmann, E., Ferrannini, E., Flyvbjerg, A., Gohlke, H., Juanatey, J. R. G., Graham, I., Monteiro, P. F., Parhofer, K., Pyorala, K., Raz, I., Schernthaner, G., Volpe, M., Wood, D. (2007). Guidelines on diabetes, pre-diabetes, and cardiovascular diseases: executive summary: The Task Force on Diabetes and Cardiovascular Diseases of the European Society of Cardiology (ESC) and of the European Association for the Study of Diabetes (EASD). Eur Heart J 28: 88-136 [Full Text]
Dzau, V. J., Antman, E. M., Black, H. R., Hayes, D. L., Manson, J. E., Plutzky, J., Popma, J. J., Stevenson, W. (2006). The Cardiovascular Disease Continuum Validated: Clinical Evidence of Improved Patient Outcomes: Part II: Clinical Trial Evidence (Acute Coronary Syndromes Through Renal Disease) and Future Directions. Circulation 114: 2871-2891 [Full Text]
Albers, G. W., Diener, H.-C., Frison, L., Grind, M., Horrow, J., Nevinson, M., Olsson, S. B., Partridge, S., Petersen, P., Vahanian, A., Halperin, J. L., on behalf of the Executive Steering Committee for, (2006). Trials and Tribulations of Noninferiority: The Ximelagatran Experience. J Am Coll Cardiol 48: 1058-1058 [Full Text]
Monte, S., Macchia, A., Pellegrini, F., Romero, M., Lepore, V., D'Ettorre, A., Saugo, M., Tavazzi, L., Tognoni, G. (2006). Antithrombotic treatment is strongly underused despite reducing overall mortality among high-risk elderly patients hospitalized with atrial fibrillation. Eur Heart J 27: 2217-2223 [Abstract] [Full Text]
Writing Committee Members, , Fuster, V., Ryden, L. E., Cannom, D. S., Crijns, H. J., Curtis, A. B., Ellenbogen, K. A., Halperin, J. L., Le Heuzey, J.-Y., Kay, G. N., Lowe, J. E., Olsson, S. B., Prystowsky, E. N., Tamargo, J. L., Wann, S., ACC/AHA Task Force Members, , Smith, S. C. Jr, Jacobs, A. K., Adams, C. D., Anderson, J. L., Antman, E. M., Halperin, J. L., Hunt, S. A., Nishimura, R., Ornato, J. P., Page, R. L., Riegel, B., ESC Committee for Practice Guidelines, , Priori, S. G., Blanc, J.-J., Budaj, A., Camm, A. J., Dean, V., Deckers, J. W., Despres, C., Dickstein, K., Lekakis, J., McGregor, K., Metra, M., Morais, J., Osterspey, A., Tamargo, J. L., Zamorano, J. L. (2006). ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation: full text: A report of the American College of Cardiology/American Heart Association Task Force on practice guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients With Atrial Fibrillation) Developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society. Europace 8: 651-745 [Full Text]
Fuster, V., Ryden, L. E., Cannom, D. S., Crijns, H. J., Curtis, A. B., Ellenbogen, K. A., Halperin, J. L., Le Heuzey, J.-Y., Kay, G. N., Lowe, J. E., Olsson, S. B., Prystowsky, E. N., Tamargo, J. L., Wann, S. (2006). ACC/AHA/ESC 2006 Guidelines for the Management of Patients With Atrial Fibrillation--Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients With Atrial Fibrillation) Developed in Collaboration With the European Heart Rhythm Association and the Heart Rhythm Society . J Am Coll Cardiol 48: 854-906 [Full Text]
Fuster, V., Ryden, L. E., Cannom, D. S., Crijns, H. J., Curtis, A. B., Ellenbogen, K. A., Halperin, J. L., Le Heuzey, J.-Y., Kay, G. N., Lowe, J. E., Olsson, S. B., Prystowsky, E. N., Tamargo, J. L., Wann, S. (2006). ACC/AHA/ESC 2006 Guidelines for the Management of Patients With Atrial Fibrillation: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients With Atrial Fibrillation) Developed in Collaboration With the European Heart Rhythm Association and the Heart Rhythm Society . J Am Coll Cardiol 48: e149-e246 [Full Text]
Singh, S. N., Tang, X. C., Singh, B. N., Dorian, P., Reda, D. J., Harris, C. L., Fletcher, R. D., Sharma, S. C., Atwood, J. E., Jacobson, A. K., Lewis, H. D. Jr, Lopez, B., Raisch, D. W., Ezekowitz, M. D., for the SAFE-T Investigators, (2006). Quality of Life and Exercise Performance in Patients in Sinus Rhythm Versus Persistent Atrial Fibrillation: A Veterans Affairs Cooperative Studies Program Substudy. J Am Coll Cardiol 48: 721-730 [Abstract] [Full Text]
Fuster, V., Ryden, L. E., Cannom, D. S., Crijns, H. J., Curtis, A. B., Ellenbogen, K. A., Halperin, J. L., Le Heuzey, J.-Y., Kay, G. N., Lowe, J. E., Olsson, S. B., Prystowsky, E. N., Tamargo, J. L., Wann, S., ACC/AHA TASK FORCE MEMBERS, , Smith, S. C. Jr, Jacobs, A. K., Adams, C. D., Anderson, J. L., Antman, E. M., Halperin, J. L., Hunt, S. A., Nishimura, R., Ornato, J. P., Page, R. L., Riegel, B., ESC COMMITTEE FOR PRACTICE GUIDELINES, , Priori, S. G., Blanc, J.-J., Budaj, A., Camm, A. J., Dean, V., Deckers, J. W., Despres, C., Dickstein, K., Lekakis, J., McGregor, K., Metra, M., Morais, J., Osterspey, A., Tamargo, J. L., Zamorano, J. L. (2006). ACC/AHA/ESC 2006 Guidelines for the Management of Patients With Atrial Fibrillation: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients With Atrial Fibrillation): Developed in Collaboration With the European Heart Rhythm Association and the Heart Rhythm Society. Circulation 114: e257-e354 [Full Text]
Fuster, V., Ryden, L. E., Cannom, D. S., Crijns, H. J., Curtis, A. B., Ellenbogen, K. A., Halperin, J. L., Le Heuzey, J.-Y., Kay, G. N., Lowe, J. E., Olsson, S. B., Prystowsky, E. N., Tamargo, J. L., Wann, S., ACC/AHA TASK FORCE MEMBERS, , Smith, S. C. Jr, Jacobs, A. K., Adams, C. D., Anderson, J. L., Antman, E. M., Halperin, J. L., Hunt, S. A., Nishimura, R., Ornato, J. P., Page, R. L., Riegel, B., ESC COMMITTEE FOR PRACTICE GUIDELINES, , Priori, S. G., Blanc, J.-J., Budaj, A., Camm, A. J., Dean, V., Deckers, J. W., Despres, C., Dickstein, K., Lekakis, J., McGregor, K., Metra, M., Morais, J., Osterspey, A., Tamargo, J. L., Zamorano, J. L. (2006). ACC/AHA/ESC 2006 Guidelines for the Management of Patients With Atrial Fibrillation--Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients With Atrial Fibrillation): Developed in Collaboration With the European Heart Rhythm Association and the Heart Rhythm Society. Circulation 114: 700-752 [Full Text]
Authors/Task Force Members, , Fuster, V., Ryden, L. E., Cannom, D. S., Crijns, H. J., Curtis, A. B., Ellenbogen, K. A., Halperin, J. L., Le Heuzey, J.-Y., Kay, G. N., Lowe, J. E., Olsson, S. B., Prystowsky, E. N., Tamargo, J. L., Wann, S., ESC Committee for Practice Guidelines, , Priori, S. G., Blanc, J.-J., Budaj, A., Camm, A. J., Dean, V., Deckers, J. W., Despres, C., Dickstein, K., Lekakis, J., McGregor, K., Metra, M., Morais, J., Osterspey, A., Tamargo, J. L., Zamorano, J. L., ACC/AHA (Practice Guidelines) Task Force Members, , Smith, S. C. Jr, Jacobs, A. K., Adams, C. D., Anderson, J. L., Antman, E. M., Halperin, J. L., Hunt, S. A., Nishimura, R., Ornato, J. P., Page, R. L., Riegel, B. (2006). ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation executive summary: A report of the American College of Cardiology/American Heart Association Task Force on practice guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients with Atrial Fibrillation) Developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society. Eur Heart J 27: 1979-2030 [Full Text]
Friberg, L., Hammar, N., Ringh, M., Pettersson, H., Rosenqvist, M. (2006). Stroke prophylaxis in atrial fibrillation: who gets it and who does not?: Report from the Stockholm Cohort-study on Atrial Fibrillation (SCAF-study). Eur Heart J 27: 1954-1964 [Abstract] [Full Text]
Bonow, R. O., Carabello, B. A., Chatterjee, K., de Leon, A. C. Jr, Faxon, D. P., Freed, M. D., Gaasch, W. H., Lytle, B. W., Nishimura, R. A., O'Gara, P. T., O'Rourke, R. A., Otto, C. M., Shah, P. M., Shanewise, J. S., Smith, S. C. Jr, Jacobs, A. K., Adams, C. D., Anderson, J. L., Antman, E. M., Faxon, D. P., Fuster, V., Halperin, J. L., Hiratzka, L. F., Hunt, S. A., Lytle, B. W., Nishimura, R., Page, R. L., Riegel, B. (2006). ACC/AHA 2006 Guidelines for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 1998 Guidelines for the Management of Patients With Valvular Heart Disease) Developed in Collaboration With the Society of Cardiovascular Anesthesiologists Endorsed by the Society for Cardiovascular Angiography and Interventions and the Society of Thoracic Surgeons. J Am Coll Cardiol 48: e1-e148 [Full Text]
Bonow, R. O., Carabello, B. A., Chatterjee, K., de Leon, A. C. Jr, Faxon, D. P., Freed, M. D., Gaasch, W. H., Lytle, B. W., Nishimura, R. A., O'Gara, P. T., O'Rourke, R. A., Otto, C. M., Shah, P. M., Shanewise, J. S., Smith, S. C. Jr, Jacobs, A. K., Adams, C. D., Anderson, J. L., Antman, E. M., Faxon, D. P., Fuster, V., Halperin, J. L., Hiratzka, L. F., Hunt, S. A., Lytle, B. W., Nishimura, R., Page, R. L., Riegel, B. (2006). ACC/AHA 2006 Practice Guidelines for the Management of Patients With Valvular Heart Disease: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 1998 Guidelines for the Management of Patients With Valvular Heart Disease) Developed in Collaboration With the Society of Cardiovascular Anesthesiologists Endorsed by the Society for Cardiovascular Angiography and Interventions and the Society of Thoracic Surgeons. J Am Coll Cardiol 48: 598-675 [Full Text]
Lakshminarayan, K., Solid, C. A., Collins, A. J., Anderson, D. C., Herzog, C. A. (2006). Atrial Fibrillation and Stroke in the General Medicare Population: A 10-Year Perspective (1992 to 2002). Stroke 37: 1969-1974 [Abstract] [Full Text]
Cooper, N. J., Sutton, A. J., Lu, G., Khunti, K. (2006). Mixed comparison of stroke prevention treatments in individuals with nonrheumatic atrial fibrillation.. Arch Intern Med 166: 1269-1275 [Abstract] [Full Text]
Somerfield, J., Barber, P. A., Anderson, N. E., Kumar, A., Spriggs, D., Charleston, A., Bennett, P., Baker, Y., Ross, L. (2006). Not All Patients With Atrial Fibrillation-Associated Ischemic Stroke Can Be Started on Anticoagulant Therapy. Stroke 37: 1217-1220 [Abstract] [Full Text]
Domanski, M. (2006). Prognosis in atrial fibrillation. Eur Heart J 27: 895-896 [Full Text]
Kerr, M. (2006). Stroke Outcomes Worse in Women. DOC News 3: 5-5 [Full Text]
Birman-Deych, E., Radford, M. J., Nilasena, D. S., Gage, B. F. (2006). Use and Effectiveness of Warfarin in Medicare Beneficiaries With Atrial Fibrillation. Stroke 37: 1070-1074 [Abstract] [Full Text]
Currie, C J, Jones, M, Goodfellow, J, McEwan, P, Morgan, C L, Emmas, C, Peters, J R (2006). Evaluation of survival and ischaemic and thromboembolic event rates in patients with non-valvar atrial fibrillation in the general population when treated and untreated with warfarin. Heart 92: 196-200 [Abstract] [Full Text]
Kaul, S., Diamond, G. A., Weintraub, W. S. (2005). Trials and Tribulations of Non-Inferiority: The Ximelagatran Experience. J Am Coll Cardiol 46: 1986-1995 [Abstract] [Full Text]
Chung, M. K., Shemanski, L., Sherman, D. G., Greene, H. L., Hogan, D. B., Kellen, J. C., Kim, S. G., Martin, L. W., Rosenberg, Y., Wyse, D. G., for the AFFIRM Investigators, (2005). Functional Status in Rate- Versus Rhythm-Control Strategies for Atrial Fibrillation: Results of the Atrial Fibrillation Follow-Up Investigation of Rhythm Management (AFFIRM) Functional Status Substudy. J Am Coll Cardiol 46: 1891-1899 [Abstract] [Full Text]
(2005). Additional Information. JAMA 294: E1-E3 [Full Text]
Waldo, A. L., Becker, R. C., Tapson, V. F., Colgan, K. J., for the NABOR Steering Committee, (2005). Hospitalized Patients With Atrial Fibrillation and a High Risk of Stroke Are Not Being Provided With Adequate Anticoagulation. J Am Coll Cardiol 46: 1729-1736 [Abstract] [Full Text]
Miyasaka, Y., Barnes, M. E., Gersh, B. J., Cha, S. S., Seward, J. B., Bailey, K. R., Iwasaka, T., Tsang, T. S.M. (2005). Time Trends of Ischemic Stroke Incidence and Mortality in Patients Diagnosed With First Atrial Fibrillation in 1980 to 2000: Report of a Community-Based Study. Stroke 36: 2362-2366 [Abstract] [Full Text]
Man-Son-Hing, M., Gage, B. F., Montgomery, A. A., Howitt, A., Thomson, R., Devereaux, P. J., Protheroe, J., Fahey, T., Armstrong, D., Laupacis, A. (2005). Preference-Based Antithrombotic Therapy in Atrial Fibrillation: Implications for Clinical Decision Making. Med Decis Making 25: 548-559 [Abstract]
Tapson, V. F., Hyers, T. M., Waldo, A. L., Ballard, D. J., Becker, R. C., Caprini, J. A., Khetan, R., Wittkowsky, A. K., Colgan, K. J., Shillington, A. C., for the NABOR (National Anticoagulation Benchmark, (2005). Antithrombotic Therapy Practices in US Hospitals in an Era of Practice Guidelines. Arch Intern Med 165: 1458-1464 [Abstract] [Full Text]
Falk, R. H. (2005). Rate Control Is Preferable to Rhythm Control in the Majority of Patients With Atrial Fibrillation. Circulation 111: 3141-3150 [Full Text]
Lim, M. J., Roychoudhury, C., Baker, P. L., Bossone, E., Mehta, R. H. (2005). Differences in quality of care among patients hospitalized with atrial fibrillation as primary or secondary cause for admission. Int J Qual Health Care 17: 255-258 [Abstract] [Full Text]
Katira, R, Chauhan, A, More, R S (2005). Direct thrombin inhibitors: novel antithrombotics on the horizon in the thromboprophylactic management of atrial fibrillation. Postgrad. Med. J. 81: 370-375 [Abstract] [Full Text]
Sherman, D. G., Kim, S. G., Boop, B. S., Corley, S. D., DiMarco, J. P., Hart, R. G., Haywood, L. J., Hoyte, K., Kaufman, E. S., Kim, M. H., Nasco, E., Waldo, A. L., for the National Heart, Lung, and Blood Institute, (2005). Occurrence and Characteristics of Stroke Events in the Atrial Fibrillation Follow-up Investigation of Sinus Rhythm Management (AFFIRM) Study. Arch Intern Med 165: 1185-1191 [Abstract] [Full Text]
Bath, P. M.W., Zhao, L., Heptinstall, S. (2005). Current status of stroke prevention in patients with atrial fibrillation. Eur Heart J Suppl 7: C12-C18 [Abstract] [Full Text]
Emmerich, J., Le Heuzey, J.-Y., Bath, P. M.W., Connolly, S. J. (2005). Indication for antithrombotic therapy for atrial fibrillation: reconciling the guidelines with clinical practice. Eur Heart J Suppl 7: C28-C33 [Abstract] [Full Text]
Schulman, S., Beyth, R. J. (2005). Risk of bleeding with long-term antithrombotic therapy in atrial fibrillation. Eur Heart J Suppl 7: C34-C40 [Abstract] [Full Text]
Senatore, G., Stabile, G., Bertaglia, E., Donnici, G., De Simone, A., Zoppo, F., Turco, P., Pascotto, P., Fazzari, M. (2005). Role of transtelephonic electrocardiographic monitoring in detecting short-term arrhythmia recurrences after radiofrequency ablation in patients with atrial fibrillation. J Am Coll Cardiol 45: 873-876 [Abstract] [Full Text]
O'Brien, C. L., Gage, B. F. (2005). Costs and Effectiveness of Ximelagatran for Stroke Prophylaxis in Chronic Atrial Fibrillation. JAMA 293: 699-706 [Abstract] [Full Text]
Page, R. L. (2004). Newly Diagnosed Atrial Fibrillation. NEJM 351: 2408-2416 [Full Text]
Reynolds, M. W., Fahrbach, K., Hauch, O., Wygant, G., Estok, R., Cella, C., Nalysnyk, L. (2004). Warfarin Anticoagulation and Outcomes in Patients With Atrial Fibrillation: A Systematic Review and Metaanalysis. Chest 126: 1938-1945 [Abstract] [Full Text]
Yousef, Z R, Tandy, S C, Tudor, V, Jishi, F, Trent, R J, Watson, D K, Cowell, R P W (2004). Warfarin for non-rheumatic atrial fibrillation: five year experience in a district general hospital. Heart 90: 1259-1262 [Abstract] [Full Text]
Ansell, J., Hirsh, J., Poller, L., Bussey, H., Jacobson, A., Hylek, E. (2004). The Pharmacology and Management of the Vitamin K Antagonists: The Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest 126: 204S-233S [Abstract] [Full Text]
Levine, M. N., Raskob, G., Beyth, R. J., Kearon, C., Schulman, S. (2004). Hemorrhagic Complications of Anticoagulant Treatment: The Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest 126: 287S-310S [Abstract] [Full Text]
Singer, D. E., Albers, G. W., Dalen, J. E., Go, A. S., Halperin, J. L., Manning, W. J. (2004). Antithrombotic Therapy in Atrial Fibrillation: The Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest 126: 429S-456S [Abstract] [Full Text]
Salem, D. N., Stein, P. D., Al-Ahmad, A., Bussey, H. I., Horstkotte, D., Miller, N., Pauker, S. G. (2004). Antithrombotic Therapy in Valvular Heart Disease--Native and Prosthetic: The Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest 126: 457S-482S [Abstract] [Full Text]
Martins, J L, Fox, K F, Wood, D A, Lefroy, D C, Collier, T J, Peters, N S (2004). Rapid access arrhythmia clinic for the diagnosis and management of new arrhythmias presenting in the community: a prospective, descriptive study. Heart 90: 877-881 [Abstract] [Full Text]
Crystal, E., Connolly, S. J (2004). Role of oral anticoagulation in management of atrial fibrillation. Heart 90: 813-817 [Full Text]
Ezekowitz, M. D., Falk, R. H. (2004). The Increasing Need for Anticoagulant Therapy to Prevent Stroke in Patients With Atrial Fibrillation. Mayo Clin Proc. 79: 904-913 [Abstract]
Hanna, I. R., Kolm, P., Martin, R., Reisman, M., Gray, W., Block, P. C. (2004). Left atrial structure and function after percutaneous left atrial appendage transcatheter occlusion (PLAATO): Six-month echocardiographic follow-up. J Am Coll Cardiol 43: 1868-1872 [Abstract] [Full Text]
Vora, A., Karnad, D., Goyal, V., Naik, A., Gupta, A., Lokhandwala, Y., Kulkarni, H., Singh, B. N. (2004). Control of Heart Rate Versus Rhythm in Rheumatic Atrial Fibrillation: A Randomized Study. J CARDIOVASC PHARMACOL THER 9: 65-73 [Abstract]
Dowd, M. B. (2004). Anticoagulation in the Elderly. Journal of Pharmacy Practice 17: 94-102 [Abstract]
Bode, C. (2004). Recent trials in atrial fibrillation: lessons learned beyond rate and rhythm. Eur Heart J Suppl 6: B15-B19 [Abstract] [Full Text]
Olsson, S.B. (2004). New advances in stroke prevention in atrial fibrillation: ximelagatran and direct thrombin inhibition. Eur Heart J Suppl 6: B20-B24 [Abstract] [Full Text]
O'Donnell, M., Hirsh, J. (2004). Establishing an Optimal Therapeutic Range for Coumarins: Filling in the Gaps. Arch Intern Med 164: 588-590 [Full Text]
Braun, M, Gliech, V, Boscheri, A, Schoen, S, Gahn, G, Reichmann, H, Haass, M, Schraeder, R, Strasser, R.H (2004). Transcatheter closure of patent foramen ovale (PFO) in patients with paradoxical embolism: Periprocedural safety and mid-term follow-up results of three different device occluder systems. Eur Heart J 25: 424-430 [Abstract] [Full Text]
Kaufman, E. S., Waldo, A. L. (2004). The impact of asymptomatic atrial fibrillation. J Am Coll Cardiol 43: 53-54 [Full Text]

Comments and questions? Please contact us.